Challenges in Translating Regenerative Therapies for Spinal Cord Injury.
Andrew N Stewart, John C Gensel, Linda Jones, Karim Fouad
PMID 38174141WHAT IT FOUND
This review analyzes why regenerative therapies for spinal cord injury struggle to move from animal studies to human trials.
It highlights mismatches in injury models, patient demographics, and rehabilitation intensity between preclinical and clinical settings.
What this paper is
This is a narrative review discussing the challenges of translating regenerative therapies for spinal cord injury from animal models to human clinical trials. It analyzes species differences, preclinical variability, and trial design issues but reports no original patient data or clinical outcomes. There are no new findings here to change clinical practice.
The easy way to misread this
Do not interpret this paper as evidence that any specific regenerative therapy or rehabilitation protocol works or fails in humans. It is a theoretical discussion about research design and translation barriers, not a report of clinical results.